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The antibody gene mutator activation-induced
cytidine deaminase (AID) promiscuously damages
oncogenes, leading to chromosomal translocations
and tumorigenesis. Why nonimmunoglobulin loci
are susceptible to AID activity is unknown. Here,
we study AID-mediated lesions in the context of nu-
clear architecture and the B cell regulome. We show
that AID targets are not randomly distributed across
the genome but are predominantly grouped within
super-enhancers and regulatory clusters. Unex-
pectedly, in these domains, AID deaminates active
promoters and eRNA+ enhancers interconnected in
some instances over megabases of linear chro-
matin. Using genome editing, we demonstrate that
3D-linked targets cooperate to recruit AID-mediated
breaks. Furthermore, a comparison of hypermuta-
tion in mouse B cells, AID-induced kataegis in
human lymphomas, and translocations in MEFs
reveals that AID damages different genes in different
cell types. Yet, in all cases, the targets are predom-
inantly associated with topological complex, highly
transcribed super-enhancers, demonstrating that
these compartments are key mediators of AID
recruitment.1524 Cell 159, 1524–1537, December 18, 2014 ª2014 Elsevier Inc.INTRODUCTION
Although humans produce roughly equal numbers of B and T
lymphocytes, up to 95% of lymphomas in the Western world
are of B cell origin (Ku¨ppers, 2005). This overrepresentation orig-
inates in large part from misrepair of DNA lesions introduced by
activation-induced cytidine deaminase (AID), a B cell-specific
cytidine deaminase that initiates class switch recombination
(CSR) and somatic hypermutation (SHM) of immunoglobulin
(Ig) genes (Alt et al., 2013). Although AID preferentially targets
Ig heavy and light chain loci, it also mutates and produces
DNA breaks in non-Ig genes (Hakim et al., 2012; Liu et al.,
2008; Robbiani et al., 2008). Among these off targets, a substan-
tial number are oncogenes directly implicated in B cell lympho-
magenesis, including BCL6, Myc, MIR142, CD95, Pax5, and
BCL7 (Chiarle et al., 2011; Hakim et al., 2012; Hasham et al.,
2010; Kato et al., 2012; Klein et al., 2011; Mu¨schen et al.,
2000; Pasqualucci et al., 1998; Robbiani et al., 2009; Shen
et al., 1998; Tsai et al., 2008). Recurrent DNA damage at these
loci leads to oncogenic mutations and chromosomal transloca-
tions that activate proto-oncogenes by juxtaposing them to
potent Ig enhancers (Nussenzweig and Nussenzweig, 2010).
Accordingly, genetic ablation of AIDmarkedly impairs the forma-
tion of Ig-translocations and the onset of B cell tumor develop-
ment in mice (Kovalchuk et al., 2007, 2012; Ramiro et al., 2004;
Robbiani et al., 2008; Takizawa et al., 2008).
Transcription facilitates AID targeting to Ig genes by at least
three related mechanisms. First, Ig enhancers are required for
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Figure 1. AID Damages Enhancer DNA
(A) Strategy to reveal AID-mediated breaks. In 53BP1/ cells DNA lesions at AID off-targets (e.g.,Cd83) in G1 are resected in S andG2M byHR repair nucleases,
leading to asymmetric RPA binding that can be detected by ChIP-Seq.
(B) The visualization of RPA-Seq was improved by plotting the difference in ChIP signals between + and – strands. An algorithm was developed to efficiently
detect asymmetric RPA occupancy. The new approach reveals two additional AID targets at the Bcl11a locus that overlap with enhancer elements (highlighted
with red asterisks). The nontargeted enhancer is marked with a blue asterisk. DNaseI, RNA (GRO-seq) (Chiarle et al., 2011), and RPA control (53BP1/AID/)
tracks are provided.
See also Figure S1 and Table S1A.hypermutation and recombination of both variable (V) domains
and switch (S) DNA repeats that precede antibody gene constant
(C) regions (Buerstedde et al., 2014). Second, transcription of S
repeats leads to substantial RNA PolII pausing (Rajagopal et al.,
2009; Wang et al., 2009), and Spt5, a PolII pausing factor, en-
ables hypermutation and recombination by associating with
AID (Pavri et al., 2010). Third, the RNA degrading exosome com-
plex displaces nascent S transcripts thereby rendering bothDNA
strands accessible to deamination (Basu et al., 2011). Whether
these or additional mechanisms are responsible for promiscuous
AID activity at non-Ig loci is unknown.
Here, we examine promiscuous AID activity and its relation-
ship to chromosome folding and the B cell regulome. We find
that AID-mediated lesions occur predominantly within B cell su-
per-enhancers and regulatory clusters. Furthermore, we show
that the structural and transcriptional features of these domains
help explain AID tumorigenic activity in the B cell compartment of
mice and humans.
RESULTS
AID Damages Enhancer DNA
To study AID off-targeting activity, we made use of replication
protein A chromatin immunoprecipitation (RPA-ChIP) that labels
DNA breaks in the 53BP1/ background (Hakim et al., 2012). B
cells isolated from these mice are defective for nonhomologous
end joining (NHEJ), and AID-mediated lesions that are induced in
G1 are aberrantly processed in S and G2M by homologousCrecombination (Yamane et al., 2013). As a result, DNA-ends
are resected leading to asymmetrical accumulation of RPA and
Rad51 around DNA breaks and these proteins can be detected
by chromatin immunoprecipitation (Figure 1A)
To improve the sensitivity of the assay, we developed an
algorithm that detects asymmetric RPA recruitment with high
precision, and the difference in ChIP signals between upper (+)
and lower () DNA strandswas plotted on a log scale (Figure 1B).
The new approach revealed 92 additional genomic sites associ-
atedwith RPA in 53BP1/IgkAIDB cells (236 total targets; Table
S1A available online). Conversely, we detected a single RPA
asymmetric peak in 53BP1/AID/ cells (not shown). At the
Bcl11a locus, for instance, we found two additional sites
downstream of the promoter (120 and 180 kb away) that display
asymmetric RPA accumulation in the presence of AID but not
in its absence (Figure 1B). Notably, a fraction of the peaks
(33, or 14%) did not overlap with TSSs but were associated
with DNaseI hypersensitive sites corresponding to B cell en-
hancers (red asterisks in Figure 1B) (Kieffer-Kwon et al., 2013).
Consistent with this interpretation, AID targets distal from
TSSs displayed the epigenetic signature of active enhancers:
H2AZlowH3K4me3lowH3K4me1high (Kouzine et al., 2013; not
shown). Thus, in addition to promoter proximal sequences, AID
damages enhancer DNA.
Nuclear Compartmentalization of AID Activity
AID activity is confined to the interphase nucleus (Petersen et al.,
2001), where the genome is partitioned into a hierarchy ofell 159, 1524–1537, December 18, 2014 ª2014 Elsevier Inc. 1525
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Figure 2. Tethering and Compartmentaliza-
tion of AID Targets in the Mouse Genome
(A) AID targets are largely found within A compart-
ments (black upper track) as defined by Hi-C. Red
dots identify the location of damaged loci within the
genomic domain. The Hi-C data was obtained from
pro-B cells. All other experiments involving mouse
B cells in the manuscript were done with activated
B cells.
(B) Circos plot shows the genome-wide distribution
of AID targets that are either tethered within regu-
latory clusters (red dots) or isolated (black dots).
(C) Upper: heat map of cis-interaction frequencies
revealing TADs within the domain chr4:42,683,983-
48,696,419. Lower: Pax5 gene regulatory cluster,
as defined by PolII long-range interactions. The
targeted promoter is associated with nondamaged
(blue asterisks) and damaged (red asterisk)
enhancers. DNaseI hypersensitivity, RNA, hyper-
mutation, and chromosomal translocations (TC-
Seq) are also shown. The number of interactions is
provided above the ChIA-PET links.
See also Figure S1.structures, including A-B compartments, topologically associ-
ating domains (TADs), and clusters of interactive gene regulatory
elements (Gibcus and Dekker, 2013). The finding that both pro-
moters and enhancers undergo AID-mediated damage suggests
that AID targets might also be clustered in the B cell nucleus. In
support of this idea, nearly half of all targets (110 of 236) were
located within 90 kb of each other, a distance that is markedly
different from a random model (4 Mb, Figure S1A). Prompted
by these observations, we analyzed the distribution of RPA+
sites in the context of genome folding, as defined by chromo-
some conformation capture (3C) techniques.
Hi-Cmaps from pro-B cells (Lin et al., 2012) revealed that 96%
of AID targets (233 of 236) are located within A compartments
(Table S1A; Figure 2A). These compartments are generally
gene-rich, DNaseI-hypersensitive, and transcriptionally active
(Lieberman-Aiden et al., 2009), features that agree well with
AID’s preference for transcribed chromatin.
In eukaryotes, TADs divide A-B compartments into nuclear
subdomains containing clusters of multiple regulatory elements
tethered by long-range interactions (Gibcus and Dekker, 2013;
Li et al., 2012). To examine the distribution of AID targets vis-a`-
vis this architecture we made use of a PolII ChIA-PET map
from activated B cells (Kieffer-Kwon et al., 2013). This technique
combines PolII ChIP with 3C technology to define the promoter-
enhancer interactome. Remarkably, while 47% of active pro-
moters in B lymphocytes are not anchored in regulatory clusters,
(Table S1A), 86% of AID targets were preferentially tethered to1526 Cell 159, 1524–1537, December 18, 2014 ª2014 Elsevier Inc.neighboring promoters and enhancers
within regulatory clusters (p < 1015, Fig-
ure 2B and Experimental Procedures). In
some cases, these clusters connected
multiple AID targets. For instance, at the
Pax5 locus the targeted promoter was
linked by long-range interactions with
three enhancer domains, one of which(250 kb away) was also damaged by AID (Figure 2C). Likewise,
the targeted Ly6a, Ly6e, andRohema promoters in chromosome
15 formed a topological cluster spanning 100 kb (Figure S1B).
Importantly, the vast majority of AID targets (84%) were tethered
to regulatory elements within the same TADs (e.g., Pax5 cluster,
Figure 2C), consistent with the notion that these domains restrict
chromatin mobility (Gibcus and Dekker, 2013). A notable excep-
tion was the histone H1 gene family, where AID targets from two
noncontiguous compartments physically associated over 2.1
Mb (Figure S1C). We conclude that AID preferentially damages
promoters and enhancers tethered by long-range interactions
within gene regulatory clusters.
AID Targeting Is Largely Confined to B Cell
Super-Enhancers
Super-enhancers (SEs) or stretch enhancers were recently iden-
tified as a special subset of regulatory elements (Hnisz et al.,
2013; Love´n et al., 2013; Parker et al., 2013; Whyte et al.,
2013). They represent exceptionally large enhancer domains pri-
marily associated with highly transcribed genes controlling cell
identity. Because of the known correlation between transcription
and AID activity, we asked whether regulatory clusters targeted
by AID might represent SE domains. To this end, we used
H3K27Ac and a published algorithm (Whyte et al., 2013) to cat-
alog SEs in stimulated B cells. Consistent with the high degree
of activation in the presence of LPS+IL-4, we uncovered 1,003
SEs in cultured B cells (Figure S2A). By comparison, 13% of 86
human tissues surveyed displayed >1,000 SEs (Hnisz et al.,
2013). In agreement with such studies, activated B cell SEs
spanned DNA regions an order of magnitude greater than con-
ventional enhancers, and they were densely occupied by the
Mediator complex (Figure S2B).
At all three Ig loci, AID-mediated damage occurred within SE
domains interconnected by long-range interactions (Figures 3A
and S2C). Remarkably, 76% (179 of 236) of all AID targets
were linked to SEs, a significant enrichment over what is ex-
pected by chance (p < 13 1015, see Experimental Procedures).
As an example, both the Aicda- and Apobec1-targeted genes
are interconnected within the same SE (Figure 3C). Thus, AID
on- and off-targeting activity occurs primarily within SE domains.
A key characteristic of SEs is that they are largely cell-type
specific. Consistent with this, more than 50% of AID-targeted
SEs were only present in stimulated B cells when compared to
18 primary mouse cells and tissues (Figure S2D). The analysis
included SEs from developing pro-B cells (Whyte et al., 2013),
which only displayed 32% overlap with activated counterparts
(Figure S2D). Hence, most AID-mediated damage occurs within
SEs acquired during development.
Approximately 80% (824 of 1,003) of B cell SEs did not harbor
AID-mediated damage (Figure 3B). Notably, SEs containing AID
targets could be distinguished from nontargeted ones in that
they were more accessible (higher H3K27Ac, p = 13 1025, Fig-
ure 3D), larger in size (p = 3  109, Figure 3E), and their associ-
ated promoters were transcribed at higher levels (p = 43 1010,
Figure 3F). In addition, the extent of 3D connectivity was signifi-
cantly higher at targeted SEs (p = 3 3 1017, Figure 3G). We
conclude that AID targets are preferentially associated with
SEs displaying a high degree of accessibility, transcription, and
structural complexity.
Functional Attributes of AID-Targeted Regulatory
Elements
Within SEs, genes undergoing AID-mediated damage are linked
to both targeted and nontargeted elements. For instance, of 11
enhancers associated with Myc, only two showed asymmetric
RPA occupancy (Figure 4A). To characterize features that might
distinguish these two enhancer groups, we measured hypersen-
sitivity to DNaseI but found no significant differences (p = 0.9,
Figure 4B). Conversely, targeted enhancers were consistently
transcribed, as determined by GRO-Seq analysis (p = 3 3
105, Figure 4C). For instance, of the two enhancers upstream
of Pax5, only the one displaying high levels of eRNA synthesis
was associated with RPA, chromosomal translocations, and
somatic hypermutation (Figure 2C). Additional examples at the
Bcl11a locus are provided in Figure 1B. Similarly, the RPA+
Myc enhancers at the mid-point of Pvt1 were transcribed at
higher levels compared to those lacking RPA (Figure 4A). Of
note, Igk translocations involving this particular Myc enhancer
cluster are selected during plasmacytomagenesis (Huppi et al.,
2011).
Consistent with eRNA synthesis, PolII and PolII long-range in-
teractions were significantly higher at enhancers associated with
AID-mediated lesions (p = 2 3 106, Figure 4D and not shown).
The PolII stalling factor Spt5, implicated in AID recruitment (Pavri
et al., 2010), was also enriched in RPA+ enhancers (p = 63 104,CFigure 4E). Importantly, these features were particularly promi-
nent at hypermutated Igh Em and Igk Ei enhancers, whereas
they were consistently low at the nontargeted Igl E3-1 and E3-
1 s enhancers (Figures 4C–4E; Table S1B). Conversely, no differ-
ences were found in the recruitment of CTCF, a factor involved in
nuclear architecture (p = 0.03, Figure 4F). A separate analysis
showed that these same features distinguished AID-targeted
from nontargeted promoters (Figure S3A). Thus, AID prefer-
entially deaminates transcriptionally active promoters and en-
hancers that engage in frequent long-range interactions.
Interacting Targets within SEs Cooperate to Recruit AID
Activity
The clustering of AID targets in themouse genome suggests that
theymay cooperate or synergize to recruit AID to SE domains. To
directly test this ideawe askedwhether a nontargeted, but other-
wise highly transcribed promoter could recruit hypermutation
when linked to a damaged gene cluster. To this end, we inserted
the ubiquitin-C (Ubc) gene promoter from chromosome 5 in lieu
of the Il4ra promoter in chromosome 7 to generate Il4rau/u mice
(Figure S3B). In activated B cells, Il4ra and flanking NsmceI and
Il21r overlap with SEs and interact extensively creating a multi-
ple-promoter gene cluster (Figure 5A). In the presence of AID,
all three genes undergo DNA double-strand breaks (Figure 5A),
whereas no damage is detected at Ubc (Figure S3C).
Fluorocytometric analysis of Il4rau/u and Il4ra+/+ B cells
showed comparable levels of cell surface Il4ra receptor (Fig-
ure S3D). Consistent with this result, knockin B cells proliferated
normally and underwent wild-type levels of g1 recombination
(Figures S3E and S3F). Importantly, H3K27Ac and RNA-Seq
showed little or no differences in SE location or expression of
Nsmce1, Il4ra, or Il21r between the two cell types (Figures 5B,
5C, and S4A). To measure chromatin contacts at the knockin
allele we applied an improved version of 4C-Seq that character-
izes local architecture at high resolution (van de Werken et al.,
2012). The analysis showed that the knocked-in Ubc promoter
associates with flanking Nsmce1 and Il21r genes at wild-type
frequencies (Figure S4B). Similar results were obtained when
using the Il21r promoter as bait (Figure S4C). Thus, neither
transcription nor the architecture of the Nsmce1-Il4ra-Il21r locus
appeared disrupted following promoter replacement.
To directly assess AID activity we bred the Il4rau allele into
the Ung/IgkAID background, which enables measurement of
hypermutation in ex-vivo cultures (Hakim et al., 2012). Il4rau/
uUng/IgkAID and Il4ra+/+Ung/IgkAID B cells were stimu-
lated for 7 days and mutations downstream of Ubc were as-
sessed at chromosomes 5 (native configuration) and 7 (knockin
alleles). Consistent with the lack of DNA breaks at Ubc in chro-
mosome 5 (Figure S3C), biological triplicates revealed back-
ground mutation at this site, comparable to the average PCR er-
ror rate measured in AID/ cells (SHM(f) = 13.6 3 105 versus
8.7 3 105; Figure 5D; Table S1B). Notably, in Il4rau/u cells
Ubc displayed a significant increase in mutation frequency in
chromosome 7 compared to its native site (SHM(f) = 59.2 3
105, fold change = 4.3, p = 0.0005, Figure 5D). Thismutation fre-
quency was nearly that of Il4ra in wild-type cells (80.5 3 105,
Figure 5D).Mir142, Pim1, andMyc, which are not directly asso-
ciated with the Il4ra locus, showed no significant changes inell 159, 1524–1537, December 18, 2014 ª2014 Elsevier Inc. 1527
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Figure 3. AID-Targeted Regulatory Clusters Are Predominantly Associated with B Cell SEs
(A) AID activity at the Igk locus occurs within a 65 kb SE domain displaying long-range chromatin interactions. PolII interactions, RPA, RNA, and H3K27Ac profiles
are provided.
(B) Venn diagram showing the fraction of AID targets associated with B cell SEs.
(C) Example of AID off-targeted SEs at the Aicda-Apobec1 TAD in chromosome 6.
(D) H3K27Ac signal at targeted and nontargeted SEs. Igm (blue, chr12:114640978-114669901), Igk (magenta, chr6:70659188-70724456), and Igl (green,
chr.16:19002804-19067747) SEs are highlighted.
(E) Size distribution of total constituent enhancers in targeted (red line) or nontargeted (black line) SEs.
(F and G) Box plots showing the absolute expression or PolII-mediated connections at targeted (red) and nontargeted (open) SEs. Data are represented as the
mean ± SEM.
See also Figure S2.
1528 Cell 159, 1524–1537, December 18, 2014 ª2014 Elsevier Inc.
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Figure 4. Defining Features of Targeted Enhancers
(A)Myc locus showing the distribution of SEs (H3K27Ac-Seq), enhancers (DNaseI-Seq), PolII long-range interactions (ChIA-PET), AID-mediated damage (RPA-
Seq), and RNA synthesis (GRO-Seq). AID-targeted enhancers are denoted with red asterisks.
(B–F) Box plots comparing the extent of protein recruitment (B), DNaseI-Seq, eRNA synthesis (C), GRO-Seq, PolII interactions (D), PETs, Spt5 (E), and CTCF
occupancy (F) at targeted (red boxes) and nontargeted (open boxes) enhancers. Data are represented as the mean ± SEM.
See also Figure S3.hypermutation following gene targeting (fold change = 1.0–1.1, p
> 0.7; Figure 5D; Table S1B). Hence, regulatory sequences at the
Nsmce1-Il4ra-Il21r locus promote AID activity at Ubc.
To determine whether the Il4ra promoter also facilitates AID
activity at flanking genes, we measured hypermutation at Il21r
and Nsmce1 in wild-type and knockin B cells. At Nsmce1, muta-Ction could not be detected above background (Figure 5D).
Conversely, at Il21r, where SHM(f) was 44.3 3 105 in wild-
type cells, we observed a statistically significant decrease in
Il4rau/u (13.2 3 105, p = 0.007, Figure 5D), indicating that
replacement of the Il4ra promoter for Ubc has a negative effect
on mutation of Il21rmore than 50 kb downstream. We concludeell 159, 1524–1537, December 18, 2014 ª2014 Elsevier Inc. 1529
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that both the Il4ra promoter and additional regulatory sequences
at the Nsmce1-Il4ra-Il21r gene cluster enable off-targeting
hypermutation by AID. The findings thus support a model where
topologically linked elements within targeted SEs cooperate to
recruit AID-mediated damage.
AID Targets in Human Lymphomas Overlap with
Regulatory Clusters and SEs
Despite the known link between AID activity and human B cell
tumor development (Klein and Dalla-Favera, 2008; Seifert
et al., 2013), a comprehensive map of AID targets in the human
genome is lacking. To directly address this question and to vali-
date our findings in mouse B cells we mapped AID activity in the
Ramos Burkitt’s lymphoma line and in primary diffuse large B cell
lymphoma (DLBCL). These tumors derive from germinal center
or postgerminal center B cells and frequently display evidence
of AID activity (Lossos et al., 2004; Pasqualucci et al., 2004;
Sale and Neuberger, 1998). To efficiently detect hypermutation
in Ramos we developed a deep-sequencing assay (SHM-Seq)
by disrupting the mismatch repair gene MSH2 by genome edit-
ing with a cassette expressing AID and Ugi, an inhibitor of the
base excision repair factor Ung (Figure S5A). The resulting cell
line is therefore both Ung- and Msh2-deficient, a combination
that in mouse B cells leads to high levels of AID-mediated tran-
sition mutations at Ig and off-target loci (Hakim et al., 2012; Liu
et al., 2008). Following 300 days of culture, the targeted cell
line was single-cell sorted, individual clones were expanded,
and DNA associated with H3K4me3, a histone mark that over-
laps with AID activity (Yamane et al., 2011), was isolated and
microsequenced (Figure S5A). Nontargeted and AID/ Ramos
cells were used as controls.
Analysis of 26 clones revealed 11,344 mutations relative to
nontargeted and AID/ controls. As expected, 92% of the sub-
stitutions were transitions. At IGH we detected 1,474 mutations
(SHM(f) = 1.0 3 102), mostly downstream of VDJ and Sm pro-
moters (Figure 6A; Table S1C). Likewise, the IGH-translocated
MYC allele was highly mutated (SHM(f) = 5.03 103, Figure 6B).
The nontranslocated MYC allele was also targeted but at a fre-
quency 20-fold lower (SHM(f) = 2.2 3 104, not shown). Other
oncogenes often targeted in human lymphomas showed evi-
dence of AID activity, including MIR142, BCL6, BCL7A, MSH6,
and ID3 (Table S1C). In total, 60 sites were hypermutated with
high confidence, including four conventional enhancers (false
discovery rate [FDR] < 1016, see Experimental Procedures).
Our mouse studies were performed with B cells overexpress-
ing AID and in ex-vivo cultures, where SHM is limited. To map
AID activity in unmanipulated cells we next performed whole-Figure 5. Tethered Regulatory Elements Cooperate to Recruit AID Act
(A) Il4ra, Il21r, and Nsmce1 form a promoter-gene cluster on mouse chromosome
mice were created by replacing the Il4ra promoter (P, blue arrow) for that of Ubc
(B) H3K27Ac in wild-type and knockin mouse B cells.
(C) mRNA expression (plotted as rpkm values).
(D) Hypermutation frequency at Ubc, Il4ra, Il21r, Nsmce1, Myc, Mir142, and Pim
cells. P values shown were calculated with Student’s t test for triplicates experim
experiments. Hypermutation at Ubcwas measured on chromosome 5 in Il4ra+/+ (b
mean ± SEM.
See also Figures S3 and S4 and Table S1B.
Cgenome sequencing (403 coverage) of ten DLBCL primary tu-
mors isolated from lymph node biopsies. Somatic substitutions
were defined by sequencing normal blood cells from the same
patients. A total of 145,997 mutations were identified concomi-
tant with deletions, insertions, amplifications, and chromosomal
translocations. To classify AID hypermutation targets with high
confidence we took advantage of the processive nature of AID
deamination, which can generate clusters of transitionmutations
in individual clones (Lada et al., 2012; Taylor et al., 2013). These
mutation showers or kataegis were recently uncovered by
whole-genome sequencing of B cell and nonhematopoietic
tumors (Alexandrov et al., 2013; Bolli et al., 2014; Chen et al.,
2014; Nik-Zainal et al., 2012; Sakofsky et al., 2014). In the
latter, particularly in breast tumors, kataegis was ascribed to
processive deamination by the AID-related enzyme APOBEC3B
(Alexandrov et al., 2013; Taylor et al., 2013).
We identified 105 kataegic sites in DLBCL associated with 30
genes (Table S1D). Four features implicated AID in the etiology
of these mutation clusters. First, 82% of kataegis overlapped
with transcribed promoter sequences, AID’s preferred targeting
domain (Figure S5B). This is in stark contrast to published non-B
cell tumors (Alexandrov et al., 2013), where <6% of the kataegis
were associated with TSSs (p < 13 1010, Figure S5B). Second,
also in contrast to other tumors, kataegis in DLBCL were recur-
rent, in that they always involved the IG loci and in most in-
stances other mouse AID targets such as PIM1, PAX5, RHOH,
CIITA,MIR142, BCL6, and the AID gene itself AICDA (Figure 6C;
Table S1D). Third, 71% of the mutations were C > T transitions,
consistent with the notion that kataegis results fromDNA replica-
tion over cytidine deamination of resected DNA (Sakofsky et al.,
2014; Taylor et al., 2013). Fourth, targeted cytidines bear the
hallmark of AID activity (Taylor et al., 2013), i.e., they occur in
a sequence context that recapitulates AID’s preference for
WRCY hotspots (Chi-square test p < 1 3 1015, Figure 6D)
(Rogozin and Kolchanov, 1992). Conversely, mutated Cs in
breast tumors only differed from the genome average in that
they were preceded mostly by a T (Figure 6D), consistent with
the deamination profile of APOBEC3B (Alexandrov et al., 2013;
Burns et al., 2013). These results thus support the proposal
that kataegis in human lymphomas stem from AID activity.
We next characterized AID targets from Burkitt’s and DLBCL
tumors in the context of nuclear architecture and SEs. To this
end we mapped PolII ChIA-PET and H3K27Ac in Ramos and
used germinal center B cells isolated from human tonsils as
substitutes for primary DLBCL (see Experimental Procedures).
Consistent with the mouse results we found a strong overlap
between hypermutated genes and SE domains (57%–70%,ivity
7. Long-range interactions, DNA damage, and SEs are shown. Il4rau/u knockin
(red arrow).
1 genes was measured in Il4ra+/+ (blue bars) and Il4rau/u (red bars) activated B
ents (Ubc, Il21r, Nsmce1) and Fisher’s exact test (Myc,Mir142, Pim1) for single
lue bar) and on chromosome 7 in Il4rau/u (red bar). Data are represented as the
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Figure 6E, p < 13 1015, see Experimental Procedures). Further-
more, 83%–85% of the targets were anchored by PolII long-
range interactions (Figure 6E). For instance, at the BCL7A gene
regulatory cluster in Ramos both the promoter and upstream en-
hancers were hypermutated (Figure S5C). Another notable
example was the BCL6 promoter and a linked SE domain >250
kb upstream (Figure 6F). Importantly, while only the BCL6 pro-
moter was associated with kataegis in DLBCL, a survey of 26 ge-
nomes from other primary human lymphomas (Alexandrov et al.,
2013) revealed the presence of kataegis at the upstream SE
domain (Figure S5D). Altogether, the results demonstrate that
both in mouse and human B cells AID mutates tethered regula-
tory elements associated with SEs and regulatory clusters.
AID Targets a Specific Microenvironment Rather Than a
Determined Set of Genes
The kataegis and SHM-Seq analyses of B cell tumors revealed
that 57%–85% of human AID targets overlap with SEs and reg-
ulatory clusters, whereas the overlap with mouse targets was
only 45%–53% (Figure 6E). The strong inference is that rather
than mutating a specific set of genes, AID targets topologically
complex, highly transcribed domains. To directly test this idea
we mapped AID-induced translocations in MEFs using TC-Seq
(Klein et al., 2011). Primary AID/ MEFs carrying I-SceI sites
at Myc and Igh (MycIIghIAID/) were transduced with I-SceI
alone or I-SceI and AID. A total of 15,272 unique, mappable
rearrangements to MycI were captured from 40 million AID/
MEFs, and 28,265 from 40 million AID-expressing MEFs (2 li-
braries each, Table S1E). Similar to B cells (Klein et al., 2011),
a large fraction (20%–44%) of the rearrangements in MEFs
occurred in cis within a 250 kb window around I-SceI (Fig-
ure S6A). Furthermore, translocations were associated with
genes more frequently than predicted by a random model (bino-
mial test p < 0.0001, Table S1E). Using stringent criteria, we
identified 29 and 43 AID-dependent translocation hotspots in
MEFs and B cells, respectively (Table S1F). Remarkably, while
the majority of these hotspots were genic (>84%), only three
(11%) were shared between fibroblasts and lymphocytes
(Figure 7A). This result indicates that the cell type alters the land-
scape of genomic rearrangements induced by AID.
Because the spatial organization of the genome is not random
but compartmentalized (Lieberman-Aiden et al., 2009), it is
possible that the cell type-restricted translocation toMycI results
from differences in nuclear organization. However, 4C-Seq
showed that theMyc interactome in fibroblasts and lymphocytes
was highly similar (Pearson’s r = 0.88, Figure S6B), consistent
with the observation that nuclear interactions do not correlateFigure 6. AID Targets in Human Lymphomas Are Associated with Lon
(A and B) The SHM-Seq protocol detects AID-mediated hypermutation in Ramo
(C) Rainfall plot displaying the distance between neighboring mutations across t
mutations are depicted with red dots. Some of the genes associated with kataeg
(D) Representation of sequence context at positions 2, 1, and +1 flanking mut
entire human genome is also shown.
(E) Percent overlap between hypermutated genes from Ramos Burkitt’s lymph
interactions (middle), or mouse AID targets (right).
(F) AID hypermutation of the BL6 regulatory cluster in Ramos cells. SEs, PolII lon
See also Figure S5 and Tables S1C and S1D.
Cwith the frequency of AID-mediated translocations (Hakim
et al., 2012).
To explore the contribution of transcription to cell type-spe-
cific targeting, we next measured RNA synthesis. We found
that, in general, genes associated with translocation hotspots
displayed higher transcription in the respective cell type (Fig-
ure S6C). For example, Pax5 and Cd83 were only targeted and
expressed in B cells, while MEF-specific hotspots Ctgf and
Wisp1 were only transcribed in fibroblasts (Figure S6D). Further-
more, while Myc was frequently translocated to the Igh I-SceI
site in MEFs, we failed to detect rearrangements to S domains,
which in fibroblasts are transcriptionally silent (Figure S6E). To
assess whether differential AID targeting was also associated
with SE domains we analyzed publicly available H3K27Ac
profiles. We found that, similar to results obtained with B cells,
AID activity at hotspot genes in MEFs occurred largely within
the context of SEs (71%, p < 1 3 1010, Figure 7B and Experi-
mental Procedures). Importantly, this correlation applied to
genes that were expressed in both cell types but were targeted
in only one of them, such as Flnb on chromosome 14 (Figure 7C)
and Pim1 on chromosome 17 (Figure S7A). Altogether, the find-
ings demonstrate that whereas AID damages a different set
of genes in MEFs and B cells, in both cell types the targets are
preferentially associated with SEs domains.
DISCUSSION
Recurrent translocation to non-Ig loci in B cell cancers is due in
part to DNA damage by AID (Chiarle et al., 2011; Hakim et al.,
2012; Klein et al., 2011; Zhang et al., 2012). However, the
genomic features responsible for recruiting DNA damage are
unknown. Our studies of mouse B cells, human lymphomas,
and MEFs reveal that a major unifying property of AID targets
is that they are predominantly clustered within highly active
SEs and regulatory clusters (Figure S7B). As discussed below,
the functional and architectural properties of these domains
help explain why their associated genes are susceptible to AID
tumorigenic activity.
SEs represent a special subset of regulatory clusters, where
chromatin accessibility and transcriptional activity are an order
of magnitude higher than at other active sites (Parker et al.,
2013; Whyte et al., 2013). Both accessibility and transcription
have long been recognized as prerequisites to Ig gene deamina-
tion (Alt et al., 2013). Our experiments show that along with size
and long-range interconnectivity, the presence of a SE can
differentiate targeted from nontargeted regulatory elements.
For instance, a model based on these combined features cang-Range Chromatin Interactions and SEs
s B cells, including at the IGH (A) and MYC (B) loci.
he genome of a DLBCL primary tumor (#129). Kataegic domains of clustered
is are highlighted.
ated Cs in DLBCL or breast cancer kataegis. The average context of Cs in the
oma (blue bars) or primary DLBCL (red bars) in SEs (left), PolII long-range
g-range interactions, and hypermutation are provided.
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Figure 7. AID Damages Different Genes in Different Cell Types
(A) Circos diagram showing hotspots of AID-dependent chromosome translocations toMycI-SceI in MEFs and B cells. Hotspots only present in B cells (blue lines),
MEFs (red lines), or both cell types (green lines) are provided.
(B) Overlap of AID targets in MEFs (red bars) or B cells (blue bars) with SEs.
(C) Myc translocations to Flnb are primarily detected in MEFs (red bars), where the gene is associated with a SE domain. Conversely, a single translocation is
detected in B cells (black bar).
See also Figures S6 and S7 and Tables S1E and S1F.accurately predict 91%ofmouse AID targets at a false discovery
rate of 9% (Figure S7C; Experimental Procedures). The underly-
ing assumption is that, as a group, these properties help create
a nuclear microenvironment highly suitable to AID-mediated
deamination. The fact that our data cannot predict AID targeting
in its totality implies that additional parameters might also be at
play. Specific transcription factors for instance have been shown
to facilitate AID recruitment to Ig genes (Buerstedde et al., 2014).1534 Cell 159, 1524–1537, December 18, 2014 ª2014 Elsevier Inc.Small RNA processing by the Exosome complex is another
example (Pefanis et al., 2014). Furthermore, in the accompa-
nying paper, Alt and colleagues uncovers a strong correlation
between convergent transcription and AID-mediated damage
(Meng et al., 2014 in this issue of Cell).
Another unexpected finding is that within targeted SEs AID not
only damages promoter proximal sequences but also cognate
enhancers. These are invariably transcribed andmore frequently
anchored by PolII long-range interactions. Both features likely
render enhancer DNA accessible to cytidine deamination and
double-strand break formation.
The link between AID activity and SEs sheds new light on the
class of genes damaged in activated and germinal center B cells.
Genome-wide maps of SHM, DNA breaks, and chromosomal
translocations have consistently uncovered two sets of genes
enriched among AID targets: oncogenes involved in proliferation
and apoptosis (e.g., Myc, Pim1, Jund, Bcl2) and genes that
feature prominently in B cell development and activation (Pax5,
Cd79b, Aicda, Irf8, Bach2, Nfkb). Although AID’s predilection
for these gene groups has been unclear, they fit well with the
observation that in all tissues examined so far, SEs largely con-
trol expression of cell identity genes as well as oncogenes that
regulate cell cycle and differentiation. Examples of these are
pluripotency genes in ES cells, genes critical for islet function
in the pancreas, and MYC in multiple myeloma (Love´n et al.,
2013; Parker et al., 2013; Whyte et al., 2013). By the same token,
our TC-Seq analysis showed that targeted SEs in MEFs control
expression of genes critical for fibroblast proliferation and matu-
ration (e.g., Ctgf, Wisp1, Amotl2).
Another defining feature of SEs is that their constituent regula-
tory elements work in cooperation or synergistically to drive gene
expression (Love´n et al., 2013). Our knockin experiments be-
tween the nontargeted Ubc promoter and the Nsmce1-Il4ra-
Il21r targeted gene cluster provide compelling evidence that
cooperation is also key to promiscuous AID-mediated damage.
This feature helps explain why AID targets are clustered in the
B cell genome. At the same time, it suggests that only networks
of functionally cooperating elements can create the proper con-
ditions for AID promiscuous activity. It is important to point out
that these conditions are not exclusive to SE domains, but that
they also typify highly interactive regulatory clusters not directly
associated with SEs (e.g., H1 gene family). The Ubc-Il4ra exper-
iment also provides a rationale to earlier observations showing
that heterologous promoters not typically damaged in germinal
centers (e.g., b-globin, B29, or PolI promoters) can recruit
hypermutation when juxtaposed to Ig enhancers (Betz et al.,
1994; Fukita et al., 1998; Tumas-Brundage and Manser, 1997).
In both cases, AID exploits long-range interactions to act at a
distance on nontargeted sequences.
In conclusion, rather than targeting a predetermined gene set,
AID tumorigenic activity is focused on nuclear microenviron-
ments that share a common set of architectural, transcriptional,
and regulatory features.EXPERIMENTAL PROCEDURES
Extended Experimental Procedures are provided in the Supplemental Informa-
tion section.
4C-Seq
The 4C assay was performed as previously described van de Werken et al.
(2012) with minor modifications. Ten million mouse B cells were crosslinked
in 2% formaldehyde at 37C for 10 min. The reaction was quenched by the
addition of glycine (final concentration of 0.125 M). Cells were then washed
with cold PBS and lysed (10 mM Tris-HCl, pH 8.0, 10 mM NaCl, 0.2% NP-40,
13 complete protease inhibitors [Roche]) at 4C for 1 hr. Nuclei were incubated
at 65C for 30 min, 37C for 30 min in 500 ml of restriction buffer (New EnglandCBioLabs DpnII buffer) containing 0.3% SDS. To sequester SDS, Triton X-100
was then added to a final concentration of 1.8%.DNAdigestionwas performed
with 400 U of DpnII (New England Biolabs) at 37C overnight. After heat inacti-
vation (65C for 30 min), the reaction was diluted to a final volume of 7 ml with
ligation buffer containing 100 U T4 DNA Ligase (Roche) and incubated at 16C
overnight. Samples were then treated with 500 mg Proteinase K (Ambion) and
incubated overnight at 65C to reverse formaldehyde crosslinking. DNA was
then purified by phenol extraction and ethanol precipitation. For circularization,
the ligation junctions were digested with Csp6I (Fermentas) at 37C overnight.
After enzyme inactivation andphenol extraction, theDNAwas religated in a7ml
volume (1,000 U T4 DNA Ligase, Roche). Three micrograms of 4C library DNA
was amplified with Expand Long template PCRSystem (Roche). Thermal cycle
conditionswereDNAdenaturing for 2min at 94C, followedby 30 cycles of 15 s
at 94C, 1 min at 58C, 3 min at 68C, and a final step of 7 min at 68C. Baits
were amplified with inverse PCR primers as follows: Il4ra with DpnII: _4C
50-TCAGGTAGTTCCATGGGATC-30, Il4ra_Csp6i 50-ATCTCTGCACCAGA-
CATCAG-30 and Il21r with IL21r_DpnII CCAGACCTACTTAGCAGATC, and
IL21r_Csp6i: ACTTAGACACTGCTCAGCTG. 4C-amplified DNA was microse-
quenced with the Illumina platform.
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The two Gene Expression Omnibus (GEO) and one Sequence Read Archive
(SRA) accession numbers for the deep-sequencing data reported in this paper
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Supplemental Information includes Extended Experimental Procedures, seven
figures, and two tables and can be foundwith this article online at http://dx.doi.
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